Subject ID, ER, tumor size, Herceptin, number of positive nodes categorized, predictive model, and randomized treatment group of participants with breast cancer and involved in the "Prediction of Trastuzumab Benefit in Adjuvant Breast Cancer: Gene Expression Profiling in NSABP B31" project.

5 Formulär

StudyEvent: SEV1

Name

Typ

Description | Question | Decode (Coded Value)

Datatyp

Alias

pht004336

Item Group

pht004336

C3846158 (UMLS CUI [1,1])

SUBJECT_ID

Item

De-identified subject ID

string

C4684638 (UMLS CUI [1,1])
C2348585 (UMLS CUI [1,2])

Item

Estrogen receptor status by IHC

text

C2919271 (UMLS CUI [1,1])
C0021044 (UMLS CUI [1,2])

Code List

Estrogen receptor status by IHC

CL Item

ER negative by IHC central review (1)

C0021044 (UMLS CUI [1,1])
C0279756 (UMLS CUI [1,2])
C5784791 (UMLS CUI [1,3])

CL Item

ER positive by IHC central review (2)

C0021044 (UMLS CUI [1,1])
C0279754 (UMLS CUI [1,2])
C5784791 (UMLS CUI [1,3])

MPSIZ

Item

Pathological tumor size

float

C1521733 (UMLS CUI [1,1])
C0475440 (UMLS CUI [1,2])

DFS

Item

Disease-free survival censoring indicator adjusted for crossover to Herceptin

text

C0242793 (UMLS CUI [1,1])
C1522602 (UMLS CUI [1,2])
C3889990 (UMLS CUI [1,3])
C0456081 (UMLS CUI [1,4])
C0338204 (UMLS CUI [1,5])

DFS

Code List

Disease-free survival censoring indicator adjusted for crossover to Herceptin

CL Item

Event free (1)

C4551700 (UMLS CUI [1,1])

CL Item

Recurrence (2)

C0034897 (UMLS CUI [1,1])

CL Item

Death (3)

C0011065 (UMLS CUI [1,1])

CL Item

Second primary cancer (5)

C0751623 (UMLS CUI [1,1])

CL Item

Local recurrence in ipsilateral breast (IBTR) (6)

C5783556 (UMLS CUI [1,1])
C0441989 (UMLS CUI [1,2])

DFStime

Item

Disease-free survival time adjusted for crossover to Herceptin

float

C0242793 (UMLS CUI [1,1])
C0456081 (UMLS CUI [1,2])
C0338204 (UMLS CUI [1,3])

NODE

Item

Number of positive nodes categorized

text

C1446409 (UMLS CUI [1,1])
C0024204 (UMLS CUI [1,2])
C0750480 (UMLS CUI [1,3])
C0871968 (UMLS CUI [1,4])

NODE

Code List

Number of positive nodes categorized

CL Item

Number of positive nodes more or equal to 1, less or equal to 3 (1)

C1446409 (UMLS CUI [1,1])
C0024204 (UMLS CUI [1,2])
C0750480 (UMLS CUI [1,3])

CL Item

Number of positive nodes more or equal to 4, less or equal to 9 (2)

C1446409 (UMLS CUI [1,1])
C0024204 (UMLS CUI [1,2])
C0750480 (UMLS CUI [1,3])

CL Item

Number of positive nodes more or equal to 10 (3)

C1446409 (UMLS CUI [1,1])
C0024204 (UMLS CUI [1,2])
C0750480 (UMLS CUI [1,3])

DV_COHORT

Item

Cohort assignment for testing predictive model

text

C0599755 (UMLS CUI [1,1])
C1516050 (UMLS CUI [1,2])
C1514306 (UMLS CUI [1,3])

DV_COHORT

Code List

Cohort assignment for testing predictive model

CL Item

Discovery (0)

C1880355 (UMLS CUI [1,1])

CL Item

Confirmation (1)

C0750484 (UMLS CUI [1,1])

TRT

Item

Randomized treatment group

text

C0034656 (UMLS CUI [1,1])
C5205742 (UMLS CUI [1,2])

TRT

Code List

Randomized treatment group

CL Item

ACT (1)

C3846158 (UMLS CUI [1,1])

CL Item

ACTH (2)

C3846158 (UMLS CUI [1,1])

Tillbaka till toppen

Subject ID, ER, tumor size, Herceptin, number of positive nodes categorized, predictive model, and randomized treatment group of participants with breast cancer and involved in the "Prediction of Trastuzumab Benefit in Adjuvant Breast Cancer: Gene Expression Profiling in NSABP B31" project.

Beskrivning

Alias

Beskrivning

Datatyp

Alias

Beskrivning

Datatyp

Alias

Beskrivning

Datatyp

Måttenheter

Alias

Beskrivning

Datatyp

Alias

Beskrivning

Datatyp

Måttenheter

Alias

Beskrivning

Datatyp

Alias

Beskrivning

Datatyp

Alias

Beskrivning

Datatyp

Alias

Similar models

Subject ID, ER, tumor size, Herceptin, number of positive nodes categorized, predictive model, and randomized treatment group of participants with breast cancer and involved in the "Prediction of Trastuzumab Benefit in Adjuvant Breast Cancer: Gene Expression Profiling in NSABP B31" project.